GI Conditions - D/O of Stomach & Duodenum - Dr. Handler Flashcards
Dyspepsia
Common GI Symptom
- Acute, chronic, or recurrent pain/discomfort
- Centered in upper abdomen
- Characterized by:
- Fullness
- Bloating
- Burning
- Nausea
- Anorexia
- “Indigestion”
Peptic Ulcer Disease
A Break in the Gastric or Duodenal Mucosa
Result of:
- Impaired normal mucosal defense factors
- Defensive factors overwhelmed by agressive luminal facors
Peptic Ulcer Disease
Location
- Duodenal bulb
- Pyloris
- Stomach
- Duodenal ulcers 5x more common than gastric
- Gastric antrum (60%)
- Lesser curvature (25%)
Peptic Ulcer Disease
Epidemiology
- 500,000 new cases/year in US
- 10-20% lifetime occurance (adults)
- Decreasing incidence since 1970s:
- Correlates with decrease H. pylori infection/successful treatment &
- Development of anti-secretory drugs
- Decreasing incidence since 1970s:
Peptic Ulcer Disease
Epidemiology
- 500,000 new cases/year in US
- 10-20% lifetime occurance (adults)
- Decreasing incidence since 1970s:
- Correlates with decrease H. pylori infection/successful treatment &
- Development of anti-secretory drugs
- Decreasing incidence since 1970s:
Peptic Ulcer Disease
Pathology
-
NSAIDS:
- Ulcers/gastritis assc. w/ long-term use
-
Helicobacter pylori infection:
- Duodenal & Gastric ulcers
-
Idiopathic:
- H. pylori negative & no NSAID use
- 5-10% of all ulcers
- Hypersecretory State
-
Smoking
- Big risk in all ulcer formation
Peptic Ulcer Disease
Pathology
Duodenal Ulcer (DU)
-
H. pylori infection
- Increases Acid
- Gastric Metaplasia in duodenal bulb
- More H. pylori infxn
- Duodenitis
- Mucosal breakdown
- DU
- Mucosal breakdown
- Duodenitis
- More H. pylori infxn
- Gastric Metaplasia in duodenal bulb
- Increases Acid
Peptic Ulcer Disease
Pathology
Gastric Ulcer (GU) & H. pylori
-
H. pylori infection of stomach
- Gastritis w/ chronic inflammation =
- defenses overwhelmed
- Mucosal breakdown
- GU
- Mucosal breakdown
Peptic Ulcer Disease
What is a necessary Co-Factor of Duodenal Ulcers & Gastric Ulcers?
- Helicobacter pylori
- (Not associated w/ NSAID ulcers)
Peptic Ulcer Disease
Helicobacter pylori
- “Hearty” bacteria
- Sprial, gram - rod
- Urease production
- Person-to-Person Spread
- Transmission…. unknown
- Incidence:
- Correlates w/ socioeconomic status
- ~25-30% US adults
- Correlates w/ socioeconomic status
Peptic Ulcer Disease
Helicobacter pylori
Associated with….
- Assc. w/ acute infectious syndrome
- Gastroenteritis
- Nausea, abd pain
- Chronic Local Infection:
- Diffuse superficial mucosal infxn
- w/ polyps & lymphocytes
- Majority of patients asymptomatic
- 15% develop PUD
- Diffuse superficial mucosal infxn
-
Eradication = CRUCIAL
- Prevent Ulcer recurrance
Peptic Ulcer Disease
Pelvic Ulcer Disease (PUD)
Signs & Symptoms, 1
- Epigastric pain common (80-90%)
- Burning, gnawing, aching
- “hunger-like”
- NOT DIAGNOSTIC
- 50% pain relief when eating +/- antacids
- Pain returns in ~2-4 hours
- Nocturnal awakening w/pain
Peptic Ulcer Disease
Pelvic Ulcer Disease (PUD)
Signs & Symptoms, 2
- Change in pain pattern
- Penetration or Perforation
- CAUTION!
- Penetration or Perforation
- Gastric Ulcers:
- Nausea/Anorexia
Peptic Ulcer Disease
Pelvic Ulcer Disease (PUD)
Physical Exam
- PE
- Often Unremarkable
- Rectal for Occult Blood
- Usually negative
Peptic Ulcer Disease
Pelvic Ulcer Disease (PUD)
Investigate/Diagnostics
- Hgb/Hct for anemia
- +/- Amylase
-
Best Diagnostic Tool:
-
Endoscopy! (EGD)
- visualize ulcer, biopsy, can test for H. pylori via histology
-
Endoscopy! (EGD)
- Imaging:
- Barium UGI
- Screening tool for dyspepsia
- Helpful, limited!
- Cannot determine benign v. malignant
- Barium UGI
Peptic Ulcer Disease
Non-Invasive H. pylori testing
-
Fecal antigen test (95% s/s):
- Indicates active infxn
-
<strong>13</strong>C-urea breath test (95% s/s):
- Indicates active infxn
- Serologic blood tests
- NO LONGER RECOMMENDED
Peptic Ulcer Disease
Gastric v. Duodenal Ulcer
-
Major Difference:
-
Gastric ulcers may be malignant (3-5%)
- Biopsy! is essential
-
Gastric ulcers may be malignant (3-5%)
- Gastric ulcers often take longer to heal than duodenal
- Require longer treatment
- Not healing GU =
- Repeat endoscopy & biopsy (malignant?)
Peptic Ulcer Disease
Treatment
- Acid-antisecretory agents
- H. pylori eradication
- Enhanced mucosal defense agents
Peptic Ulcer Disease
Treatment
- Acid-Antisecretory Agents*
- *Healing Time**
- >90% of DU heal in 4wks
- >90% GU heal in 8 weeks
Peptic Ulcer Disease
Treatment
Acid-Antisecretory Agents
-
Proton Pump Inhibitors (PPI):
- Inactive the H+-K+ ATPase (proton) pump in the stomach
- Short 1/2 life
- 24hr pump inactivation allows 1-2x daily Rx
- oral agents
- Inhibit>90% acid secretion
PPIs are preferred Rx for PUD
Peptic Ulcer Disease
Treatment
- Acid-Antisecretory Agents*
- Characteristics*
- Safe, low side effect profile
- Minor GI/CNS SEs
- Ex:
- Omeprazole, Lansoprazole
- 2x BID while eradicating H. pylori, then QID
Ulcers likely to recur unless ERADICATE H. pylori
Peptic Ulcer Disease
Treatment
- Other Acid-Antisecretory Agents:*
- H2 receptor antagonists*
- H2 receptor antagonists
- Inhibit histamine mediated gastric acid secretion
- Suppress nocturnal >waking/post-meal acid secretion
- Less effective than PPI, but most ulcers heal (85-90% efficacy) over 6-8 weeks
Peptic Ulcer Disease
Treatment
- Other Acid-Antisecretory Agents:*
- H2 receptor antagonists*
-
Ranitidine, Famotidine
- & others (all OTC)
- Safe
- Taken as single, large PO dose at night
- Available in IV form for gastritis prophylaxis
Peptic Ulcer Disease
Treatment
Mucosal Defense Agents
-
2nd line or adjunct Rx of PUD
- 1st line: Antisecretory Agents
-
Antacids
- buffer acid
- rapid
- symptom relief
- supplemental Rx
-
Sucralfate
- Adheres to ulcer craters & protects cells
- Allows healing
-
Bismuth
- Anti-bacterial v. H. pylori
- Enhances mucosal defenses